| Course | BHA FPX 3010 Introduction to Healthcare Research Methods |
|---|---|
| Assessment | Assessment 2 |
| Paper type | Study appraisal |
| Length | About 1,090 words, 5 pages |
| Format | APA 7 student paper |
| School | Capella University |
| Program | BS in Health Care Administration |
| Updated | September 2026 |
Free sample paper for BHA FPX 3010 Assessment 2
Appraising a Study for a Management Decision: The Randomized Trial of Hospital-Level Care at Home
Student Name
Capella University
BHA FPX 3010: Introduction to Healthcare Research Methods
Instructor Name
Month Day, Year
The Study Named and Briefly Described
Levine et al. (2020) conducted a randomized controlled trial of hospital-level care at home for adults with acute medical conditions who would otherwise have been admitted to the hospital. The study took place at two hospitals in one health system in Boston. Adults who presented to the emergency department with conditions such as heart failure, pneumonia, chronic obstructive pulmonary disease exacerbation, and cellulitis, and who needed admission, were randomly assigned either to usual hospital care or to care at home, which included daily physician or nurse practitioner visits, at least two nurse or paramedic visits a day, remote monitoring, and the ability to provide intravenous medications, oxygen, and imaging at home. The primary outcome was the total direct cost of the acute care episode. Secondary outcomes included use of services, physical activity, readmissions, and patient experience. The study reported that the adjusted mean direct cost of the acute care episode was about 38% lower for home patients, that home patients had fewer laboratory tests, imaging studies, and consultations, that they spent more time physically active, and that fewer were readmitted within 30 days.
Why This Study Matters for a Management Decision
Summit Health, a composite regional health system, is considering a hospital-at-home program. Its leaders want to know whether the evidence supports the claim that such programs reduce costs without harming patients, and how much weight a single trial can bear in that decision. This appraisal examines whether the study supports that claim for Summit.
Whether the Sample Supports the Claim
The study randomized 91 patients, 43 to home care and 48 to hospital care. The sample is small for a study of this importance. Randomization gives confidence that the groups were similar at the start, but a small sample means that estimates are imprecise, especially for uncommon outcomes such as readmissions, where a few events can change the percentages substantially. The sample was also selective: patients had to meet clinical criteria, live within a set distance of the hospital, have a safe home setting, and agree to participate. Many emergency department patients were not eligible, and some eligible patients declined. The results therefore apply to a selected group of relatively stable patients with suitable homes, not to all patients needing admission. The study took place in two hospitals within one academic health system in a large city. Summit's patient population, staffing, and geography differ, and costs in a home program depend on travel distances and staffing models. A sample of 91 selected patients in one city can show that a program works there, but not how large the effect would be elsewhere.
Measurement and Validated Instruments
The primary outcome, total direct cost, was measured using the health system's cost accounting data for hospital patients and estimated costs for home services, including staff time, equipment, and supplies. Measuring costs in the two settings using different methods introduces some uncertainty, since the home program's costs were partly estimated. Physical activity was measured using accelerometers, an objective method. Patient experience was measured with a standardized patient experience survey. Readmissions were measured from health system records, which may miss readmissions to other hospitals. Understanding how each outcome was measured tells the reader how much confidence each result deserves: the objective activity measure is strong, while the cost comparison depends on assumptions.
Effect Size Read, Not P Values Recited
A 38% lower cost is a large effect, and it is the most important number for a management decision. However, with 91 patients, the confidence interval around the cost difference is wide, which means the true effect could be considerably smaller or larger than 38%. The readmission difference is also large in percentage terms but based on a small number of events, so its true size is uncertain. For Summit, the practical question is not whether a p value was below .05 but whether the plausible range of savings is large enough to justify starting a program. Even a much smaller saving, combined with the reduced use of tests and improved activity, could be meaningful if Summit's own costs allow it.
Other Threats to Validity
The study could not blind patients or clinicians, since everyone knew whether care was at home or in the hospital. Knowing the assignment could affect decisions, for example if home clinicians ordered fewer tests because they were motivated to show the program's value. The outcomes most at risk from this bias, such as test use, are the ones that drive part of the cost difference. The study also followed patients for a limited period, so longer-term effects are not known. And because the home program was newly established and staffed by clinicians committed to it, its results may be better than a routine program would achieve once the novelty fades.
What Summit Should Measure in Its Own Pilot
If Summit starts a pilot, it should measure the same outcomes the study measured, using its own cost accounting data, so that its results can be compared with the published findings. It should also track outcomes the study could not fully address in a small sample, such as falls at home, escalations back to the hospital, and staff travel time. Recording how many patients were screened, how many were eligible, and how many agreed would show how large a program Summit's population can support.
The Conclusion the Study Can Carry
The study can carry this conclusion: for carefully selected adults with common acute conditions in an academic health system, hospital-level care at home produced lower costs, fewer tests, more physical activity, and no evidence of worse outcomes than usual hospital care. It cannot carry a conclusion that hospital-at-home would reduce costs by 38% at Summit, or that it is safe for all patients needing admission. For Summit, the study supports starting a small program with similar selection criteria, measuring its own costs and outcomes, and expanding only if local results confirm the benefits.
Conclusion
The trial by Levine et al. (2020) is a well-designed randomized study that supports the value of hospital-level care at home for selected patients. Its small sample, selective eligibility, single-system setting, and estimated home costs limit how far its results can be applied, and its large effect sizes should be read with their uncertainty. The study supports a cautious local pilot rather than a large-scale commitment.
References
Levine, D. M., Ouchi, K., Blanchfield, B., Saenz, A., Burke, K., Paz, M., Diamond, K., Pu, C. T., & Schnipper, J. L. (2020). Hospital-level care at home for acutely ill adults: A randomized controlled trial. Annals of Internal Medicine, 172(2), 77-85.
The Capella BHA FPX 3010 Assessment 2 instructions
The instructions ask you to appraise a published research study and judge whether it can inform a health care management decision. You give the full citation and summary, assess the design, sample, measures, results and threats to validity, interpret effect sizes and confidence intervals in practical terms, and explain what the findings mean for a specific organization. The study should be relevant to a real decision, such as starting a program or changing a process. Appraisal checklists, such as those from CASP or the Joanna Briggs Institute, can structure the review. The paper should be balanced, noting strengths as well as weaknesses. Several supporting sources may be used, but one study is the focus.
How the BHA-FPX3010 Assessment 2 example is put together
The example opens with a full citation and a two or three sentence account of the study, enough that a reader who has not seen the paper can follow the appraisal. Then it moves criterion by criterion. Design comes first, with the question the study was answering and whether the design could answer it. Sampling follows: who was included, who was left out, how many, and what that does to generalizability. Measurement is next, covering the instrument used and whether it was validated for this population. The analysis section reads effect size and confidence intervals rather than reciting p values. A limitations paragraph separates what the authors admitted from what they left unsaid. The example closes with an application judgment for a named healthcare setting.
Where the marks sit in the BHA FPX 3010 Assessment 2 scoring guide
The scoring guide rates the summary, the design appraisal, the sample, the measurement, the results interpretation and the application. The design reaches Distinguished when the question the study answered is stated and the design judged against it. Sample appraisal scores higher when the paper asks whether the participants resemble the organization's patients. Measurement earns credit when validated instruments are noted. Results should be read as effect sizes and intervals, such as the difference in cost per episode, not as a list of p-values. Other threats to validity, such as a single-site trial, should be named. Application to the organization shows judgment. Writing and APA are graded.
BHA FPX 3010 Assessment 2 help from the desk
Students often summarize a study without appraising it. Another common mistake is reciting p-values without explaining what the size of the effect means for a manager. Sample differences between the study and the organization are ignored, so findings from an academic center are assumed to apply to a rural hospital. Threats to validity are listed generically. Application is missing, which is the point of the assessment. Only weaknesses are reported, though a fair appraisal also says what the trial did well. A short paragraph at the end stating what the organization should measure if it tried the program turns the appraisal into a decision tool.
Get a BHA FPX 3010 Assessment 2 example written to your instructions
Send the assessment instructions and the scoring guide from your courseroom, along with the study you were assigned or the one you picked. We write a custom BHA FPX 3010 Assessment 2 appraisal example against those criteria and return it in 24 to 48 hours. The first custom sample is free, and it appraises the study you are actually working with. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.
More BHA FPX 3010 papers and BS in Health Care Administration samples
- BHA FPX 3010 Assessment 1: Research Question and Design
- BHA FPX 3010 Assessment 3: Research Proposal
- BHA FPX 3108 Assessment 2: Management Strategy
- BHA FPX 3009 Assessment 2: Revenue Cycle Analysis
- BHA FPX 3112 Assessment 2: Supply and Demand Analysis
- BHA FPX 3008 Assessment 2: Variance Report
BHA FPX 3010 Assessment 2 questions, answered
Can I appraise any study I find online?
Usually the instructions set boundaries, most often a peer reviewed primary study published within a stated window and relevant to healthcare administration. Reviews, editorials and vendor white papers cause trouble, because the appraisal criteria ask about sampling and analysis that those pieces do not report. Check your instructions first, then pick a study that reports its methods in enough detail to be judged.
How is this different from a literature review?
A review synthesizes many sources and reports what the body of evidence says. This deliverable does the opposite: it takes one study and interrogates how it was built. The unit of work is the method, not the topic. That is why the example spends most of its length on sampling, measurement and analysis, and only a short paragraph restating what the study found.
Do I have to criticize the study?
You have to judge it, which is not the same thing. A strong appraisal names what the study does well with the same specificity it uses for weaknesses, then states what the findings can and cannot support. Manufactured criticism reads as poorly as uncritical praise. The example praises the sampling in one place and questions the measurement in another, both with reasons.
Where can I find a free BHA FPX 3010 Assessment 2 sample paper?
The hospital-at-home trial appraisal is reproduced here start to finish, with design, sample, measures, effect sizes, threats to validity and what to measure in a pilot. A custom appraisal is available free.
What does it mean to read effect sizes in BHA FPX 3010 Assessment 2?
Report how large the difference was and its confidence interval, then say what that means in practice, such as dollars saved per patient or readmissions avoided, instead of only whether it was statistically significant.